Brokers Offer Predictions for RVPH Q1 Earnings
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH – Free Report) – Investment analysts at Roth Capital issued their Q1 2026 earnings per share estimates for shares of Reviva Pharmaceuticals in a report released on Friday, April 4th. Roth Capital analyst B. Pachaiyappan forecasts that the company will post earnings of ($0.16) per share for the quarter. Roth […]
